Search

for
Search:

Sort by

Research

990-1000 / 1000+ results

Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial

research Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial

19 citations , December 2021 in “Cureus”

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Bariatric Surgery for Spontaneous Ovulation in Women with Polycystic Ovary Syndrome: The BAMBINI Multicentre, Open-Label, Randomised Controlled Trial

research Bariatric surgery for spontaneous ovulation in women living with polycystic ovary syndrome: the BAMBINI multicentre, open-label, randomised controlled trial

4 citations , May 2024 in “The Lancet”

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

research Scalp hypothermia as a preventative measure for chemotherapy‐induced alopecia: a review of controlled clinical trials

37 citations , October 2017 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology”

Scalp cooling effectively reduces hair loss from chemotherapy.

research Comparison of efficacy of platelet-rich plasma therapy with or without topical 5% minoxidil in male-type baldness: A randomized, double-blind placebo control trial

26 citations , December 2019 in “Indian Journal of Dermatology, Venereology and Leprology”

PRP combined with minoxidil is the most effective and safe treatment for male pattern baldness.

research Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours

22 citations , May 2011 in “European Journal of Cancer”

The drug combination was safe and showed promise in treating advanced tumors.

research Comparison of clinical trials with finasteride and dutasteride.

20 citations , January 2004 in “PubMed”

Dutasteride reduces DHT more than finasteride, but both drugs improve BPH symptoms similarly.

Cyanidin 3-O-Arabinoside Suppresses DHT-Induced Dermal Papilla Cell Senescence by Modulating p38-Dependent ER-Mitochondria Contacts

research Cyanidin 3-O-arabinoside suppresses DHT-induced dermal papilla cell senescence by modulating p38-dependent ER-mitochondria contacts

14 citations , March 2022 in “Journal of Biomedical Science”

Cyanidin 3-O-arabinoside may help treat a common form of hair loss by protecting cells against aging and improving cell function.

research Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial

6 citations , June 2021 in “EClinicalMedicine”

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

research A Nonrandomized Clinical Trial Investigating Keratinocyte Growth Factor‐Hair Serum for the Prevention of Chemotherapy‐Induced Alopecia

March 2026 in “Journal of Cosmetic Dermatology”

Keratinocyte Growth Factor-Hair Serum may help prevent hair loss during chemotherapy, but more research is needed.

research Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study

February 2026 in “Journal of Dermatological Treatment”

CG2001 is safe and well-tolerated for treating hair loss, with fewer side effects than oral finasteride.

← Previous page